FindTrial
Sign In

Comparison of the incidence of perioperative cardiovascular risk events among mammary cancer patients with and without a history of neoadjuvant chemotherapy

Comparison of the incidence of perioperative cardiovascular risk events among mammary cancer patients with and without a history of neoadjuvant chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16009832
Enrollment
Unknown
Registered
2016-11-11
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative cardiovascular risk events in mammary cancer

Interventions

Case series:radical mastectomy under general anesthesia

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
24 Years to 79 Years

Inclusion criteria

Inclusion criteria: Aged 18–65 years and radical mastectomy under general anesthesia.

Exclusion criteria

Exclusion criteria: Patients were excluded if they met any of the following criteria: (1) preoperative acid–base imbalance and electrolyte disorders or severe liver and kidney dysfunction; (2) existing coronary heart disease or arrhythmias before surgery; (3) myocardial ischemia or myocardial enzyme changes present before surgery; and (4) excessive blood loss or Hb <7 g/dl requiring blood transfusion.

Design outcomes

Primary

MeasureTime frame
cardiovascular risk events;—

Countries

China

Contacts

Public ContactJun Fang

Zhejiang Cancer Hospital

fangjun477@zjcc.org.cn+86 13606617457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026